Natural history of chronic hepatitis B virus infection

Journal of Gastroenterology and Hepatology (Australia)

Volumn 15, Issue SUPPL. MAY, 2000, Pages

  Yuen, Man Fung ^a   Lai, Ching Lung ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONICITY; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE COURSE; DISEASE DURATION; HEPATITIS B; HUMAN; IMMUNE RESPONSE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; ONSET AGE; PRIORITY JOURNAL; RACE DIFFERENCE; SEROCONVERSION; VIRUS GENOME; VIRUS TRANSMISSION;

EID: 0033938327     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2000.02123.x     Document Type: Conference Paper

References (21)

1. Kane MA. Progress on the control of hepatitis B infection through immunization. Gut 1988; 29: 967-9.
2. Beasley RP, Hwang L-Y. Overview on the epidemiology of hepatocellular carcinoma. In: Hollinger FB, Lemon SM, Margolis H, eds. Viral Hepatitis and Liver Disease. Baltimore: Williams & Wilkins, 1991; 532-5.
3. Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc. Nat. Acad. Sci. USA 1987; 6599-603.
4. Hoofnagle JH, Shafritz DA, Popper H. Chronic type B hepatitis and the 'healthy' HBsAg carrier state. Hepatology 1987; 7: 758-63.
5. Sanchez-Tapias JM, Vilar JH, Costa J, Bruguera M, Ballesta AM, Rodes J. Natural history of chronic persistent hepatitis B: Relationship between hepatitis B virus replication and the course of the disease. J. Hepatol. 1985; 1: 15-27.
6. Fattovich G, Rugge M, Brollo L et al. Clinical, virologic and histologie outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology 1986; 6: 167-72.
7. Villeneuve J-P, Desrochers M, Infante-Rivard C et al. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology 1994; 106: 1000-5.
8. Kuhns M, McNamara A, Mason A, Campbell C, Perrillo R. Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen. Gastroenterology 1992; 103: 1649-56.
9. Brechot C, Nalpas B, Courouce AM et al. Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcoholic liver disease. N. Engl. J. Med. 1982; 306: 1384-7.
10. Maruyama T, Shiro I, Koike K, Yasuda K, Milich DR. Serology of acute exacerbation in chronic hepatitis B virus infection. Gastroenterology 1993; 105: 1141-51.
11. Lok ASF, Lai CL, Wu PC, Leung EKY, Lam TS. Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology 1987; 92: 1839-43.
12. Sheen IS, Liaw YF, Tai DI, Chu CM. Hepatic decompensation associated with hepatitis B e antigen clearance in chronic type B hepatitis. Gastroenterology 1985; 89: 732-5.
13. Liaw YF, Tai DI, Chu CM, Chen TJ. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 1988; 8: 493-6.
14. Chang MH, Hsu HY, Hsu HC, Ni YH, Chen JS, Chen DS. The significance of spontaneous hepatitis B e antigen seroconversion in childhood: with special emphasis on the clearance of hepatitis B e antigen before 3 years of age. Hepatology 1995; 22: 1387-92.
15. Lok ASF, Akarca U, Greene S. Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encepsidation signal. Proc. Natl. Acad. Sci. USA 1994; 91: 4077-81.
16. Li JS, Tong SD, Wen YM, Vitvitski L, Zhang Q, Trepo C. Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region. J. Virol. 1993; 67: 5402-10.
17. Chan HLY, Hussain M, Lok ASF. Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion. Hepatology 1999; 29: 976-84.
18. Lai CL. New treatment strategies in hepatitis B and C. antiviral therapy for hepatitis B and C in Asians. J. Gastroenterol. Hepatol 1999; 14 (Suppl.): S19-21.
19. Yuen MF, Wong WM, Cheng CC, Wu CH, Wu PC, Lai CL. Natural history of chronic hepatitis B in the Chinese: prognostic significance of HBeAg/anti-HBe positivity. Hepatology 1997; 26 (Suppl.): A751.
20. Huo TI, Wu JC, Lee PC et al. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 1998; 28: 231-6.
21. McMahon BJ. Chronic carriers of hepatitis B virus who clear hepatitis B surface antigen: Are they really 'off the hook'? Hepatology 1998; 28: 265-7.